Cyphostemma adenocaule
Cyphostemma adenocaule · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cyphostemma adenocaule is a specialized plant species known for its significant pharmacological potential in traditional medicine. Research indicates that the crude root extract and various solvent fractions, such as the n-butanol fraction, possess diverse bioactive properties. These preparations have been investigated for their efficacy in treating conditions including helminthiasis and splenomegaly. Furthermore, the plant shows medicinal promise in addressing the complications arising from snakebite and snake envenomation. Through these various extraction methods, the medicinal value of its roots is being systematically explored.
- Synonyms
- Cissus Adenocaulis · Vitis Adenocaulis
- Common names
- Not available
- Family
- Vitaceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Synonyms
Cyphostemma adenocaule is a botanical species that is frequently identified by various other scientific names in different taxonomic records. In many historical contexts, this plant is recognized by the synonym Cissus adenocaulis. Researchers may also encounter it listed under the name Vitis adenocaulis depending on the classification system being used. These overlapping designations highlight the evolving nature of plant taxonomy and the complexities of botanical nomenclature. Understanding these synonyms is essential for anyone studying the diverse lineage of this particular species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Cyphostemma adenocaule is a specialized organism belonging to the vast kingdom Plantae. Within this diverse biological realm, the plant is classified under the class Equisetopsida. It further occupies a specific niche as a member of the order Vitales. This botanical specimen is nested within the family Vitaceae, which links it to other grape-like relatives. Ultimately, it is defined by its unique identity within the genus Cyphostemma.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Vitales |
| Family | Vitaceae |
| Genus | Cyphostemma |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cyphostemma adenocaule is a unique plant species found across several diverse regions of the African continent. Its distribution spans much of East Tropical Africa, including prominent presence in Kenya, Tanzania, and Uganda. Beyond the eastern reaches, the species also extends into Northeast Tropical Africa. Specifically, it can be located within the territories of Chad and Eritrea. This widespread range highlights the plant's ability to thrive across various tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cyphostemma adenocaule is characterized by its distinctive growth form as a herbaceous plant. It possesses an obligatory climbing habit, relying on other structures for support as it ascends. This specialized climber typically reaches a maximum height of approximately 4 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Cyphostemma adenocaule is utilized in various indigenous medicinal systems to treat helminthiasis and other immunological disorders. Traditional practitioners also rely on this plant to manage the rabies virus. Furthermore, the species is recognized for its ability to treat snake envenomation. In the Afar Regional State of Ethiopia, it is specifically noted as a preferred medicinal plant for combating snakebite.
Preparations
Cyphostemma adenocaule is prepared as a crude extract to evaluate its immunomodulatory potential in scientific studies. The plant is also specifically prepared as a crude root extract for in-vivo testing on Swiss albino mice. Researchers utilize various solvent fractions derived from the plant to compare biological activities. Among these preparations, the n-butanol fraction of the plant has been identified as showing promising immunostimulant activity. These different preparations, including the crude extract and solvent fractions, are essential for assessing the plant's ability to enhance carbon clearance rates and humoral antibody titers.
Parts used
Cyphostemma adenocaule is a plant utilized in various indigenous medicinal systems for managing a wide array of immunological disorders. Traditional practices, such as those in Ethiopia, have long employed this species to treat conditions ranging from tumors to snake envenomation. Recent scientific investigations have focused specifically on the pharmacological potential of the plant's root. By evaluating the crude root extract and its solvent fractions, researchers aim to validate these long-standing medicinal claims. The study concludes that the crude extract demonstrates promising immunostimulant activity, particularly through the enhancement of carbon clearance rates and humoral antibody titers.